Director/PDMR Shareholding
Quirin Bank AG
€3.84
12:15 25/04/24
20 March 2020
Notification of Transactions by Persons Discharging Managerial Responsibilities
Great Portland Estates plc (the Company) has been notified that on 19 March 2020 Richard Mully, a Non-Executive Director, purchased 10,000 ordinary shares of 155/19 p in the Company at a price of 529.64 pence per share.
The relevant notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
1. | Details of PDMR/person closely associated with them ("PCA") | ||
a) | Name | Richard Mully | |
2. | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification/amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, action platform, auctioneer or auction monitor | ||
a) | Name | Great Portland Estates plc
| |
b) | Legal Entity Identifier | 213800JMEDD2Q4N1MC42 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument | Ordinary shares of 155/19 p ISIN: GB00BF5H9P87 | |
b) | Nature of the transaction | Purchase of shares | |
c) | Price(s) and volume(s) | Price | Volume(s) |
529.64p | 10,000 | ||
d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total |
Aggregated volume: 10,000 Aggregated price: 529.64p Aggregated total: £52,964.40 | |
e) | Date of transaction | 19 March 2020 | |
f) | Place of the transaction | London Stock Exchange (XLON) |
Contact:
Great Portland Estates plc
Julie McLeod
Deputy Company Secretary
020 7647 3000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.